Technical Analysis for OBD - Oxford Biodynamics Plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | 0.00% | |
| New Uptrend | Bullish | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 4.38% | |
| Narrow Range Bar | Range Contraction | 4.38% | |
| Outside Day | Range Expansion | 4.38% | |
| Bollinger Band Squeeze | Range Contraction | 4.97% | |
| Narrow Range Bar | Range Contraction | 4.97% | |
| Bollinger Band Squeeze | Range Contraction | 4.38% | |
| Narrow Range Bar | Range Contraction | 4.38% |
Get this analysis on your stocks daily!
Oxford Biodynamics Plc Description
Oxford BioDynamics Plc is a biotechnology company, which is engaged in biomarker research and development. The Company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. Its geographical segments include UK and Malaysia. Its EpiSwitch is an industrial platform for the discovery, evaluation, validation and monitoring of a class of epigenetic biomarkers known as chromosome conformation signatures (CCSs). EpiSwitch is a biomarker technology platform that facilitates pharmaceutical and biotechnology companies in their therapeutic development programs and the development of companion diagnostics. The EpiSwitch technology has validated biomarkers in a range of diseases, including Alzheimer's disease, breast cancer, ulcerative colitis and liver cancer. Its service offering includes predictive biomarkers, prognostic biomarkers, residual disease monitoring biomarkers, diagnostic biomarkers and companion diagnostic biomarkers.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Pharmaceutical Medicine Valuation Cancer Disease Branches Of Biology Monitoring Nature Clinical Medicine Diseases Evaluation Xf Biomarker Biomarkers Alzheimer's Disease Eim Validation Dynamics Ulcerative Colitis Biotechnology Companies Breast Cancer Biotechnology Industry Companion Diagnostic Imaging Biomarker Liver Cancer
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 51.7 |
| 52 Week Low | 8.3751 |
| Average Volume | 537,090 |
| 200-Day Moving Average | 19.57 |
| 50-Day Moving Average | 11.18 |
| 20-Day Moving Average | 9.14 |
| 10-Day Moving Average | 8.82 |
| Average True Range | 0.65 |
| RSI (14) | 41.18 |
| ADX | 31.26 |
| +DI | 18.55 |
| -DI | 17.26 |
| Chandelier Exit (Long, 3 ATRs) | 8.34 |
| Chandelier Exit (Short, 3 ATRs) | 10.33 |
| Upper Bollinger Bands | 9.91 |
| Lower Bollinger Band | 8.37 |
| Percent B (%b) | 0.6 |
| BandWidth | 16.78 |
| MACD Line | -0.73 |
| MACD Signal Line | -0.94 |
| MACD Histogram | 0.2192 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 10.80 | ||||
| Resistance 3 (R3) | 10.80 | 10.30 | 10.55 | ||
| Resistance 2 (R2) | 10.30 | 9.92 | 10.30 | 10.46 | |
| Resistance 1 (R1) | 9.79 | 9.68 | 10.05 | 9.79 | 10.38 |
| Pivot Point | 9.30 | 9.30 | 9.42 | 9.29 | 9.30 |
| Support 1 (S1) | 8.79 | 8.91 | 9.04 | 8.79 | 8.20 |
| Support 2 (S2) | 8.29 | 8.67 | 8.29 | 8.12 | |
| Support 3 (S3) | 7.79 | 8.29 | 8.03 | ||
| Support 4 (S4) | 7.78 |
